Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Restorelle® Mesh Versus Native Tissue Repair for Prolapse
Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center, National Center for Advanced Pelvic Surgery
mi
from
Washington,
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center, National Center for Advanced Pelvic Surgery
mi
from
Washington,
Click here to add this to my saved trials
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Research Center
mi
from
Bronx, NY
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Research Center
mi
from
Bronx, NY
Click here to add this to my saved trials
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated:  12/31/1969
Recruiting
mi
from
Charlottesville, VA
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated: 12/31/1969
Recruiting
mi
from
Charlottesville, VA
Click here to add this to my saved trials
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated:  12/31/1969
Recruiting
mi
from
Miami, FL
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated: 12/31/1969
Recruiting
mi
from
Miami, FL
Click here to add this to my saved trials
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated:  12/31/1969
Recruiting
mi
from
Augusta, GA
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated: 12/31/1969
Recruiting
mi
from
Augusta, GA
Click here to add this to my saved trials
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated:  12/31/1969
Recruiting
mi
from
Bronx, NY
ADXS11-001 High Dose HPV+ Cervical Cancer
PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX
Status: Enrolling
Updated: 12/31/1969
Recruiting
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease
Status: Enrolling
Updated:  12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease
Status: Enrolling
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated:  12/31/1969
DeClaire LaMacchia Orthopaedic Institute
mi
from
Rochester Hills, MI
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated: 12/31/1969
DeClaire LaMacchia Orthopaedic Institute
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated:  12/31/1969
Joint Implant Surgeons, Inc.
mi
from
New Albany, OH
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated: 12/31/1969
Joint Implant Surgeons, Inc.
mi
from
New Albany, OH
Click here to add this to my saved trials
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated:  12/31/1969
Midwest Orthopaedics at Rush University Medical Center
mi
from
Chicago, IL
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated: 12/31/1969
Midwest Orthopaedics at Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated:  12/31/1969
University of Utah Orthopaedic Center
mi
from
Salt Lake City, UT
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated: 12/31/1969
University of Utah Orthopaedic Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated:  12/31/1969
Missouri Orthopaedic Institute
mi
from
Columbia, MO
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated: 12/31/1969
Missouri Orthopaedic Institute
mi
from
Columbia, MO
Click here to add this to my saved trials
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated:  12/31/1969
Texas Center for Joint Replacement
mi
from
Plano, TX
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Status: Enrolling
Updated: 12/31/1969
Texas Center for Joint Replacement
mi
from
Plano, TX
Click here to add this to my saved trials
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Status: Enrolling
Updated:  12/31/1969
Department of Urology, Loma Linda University
mi
from
Loma Linda, CA
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Status: Enrolling
Updated: 12/31/1969
Department of Urology, Loma Linda University
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency
Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency: An Exporatory Pilot Study.
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency
Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency: An Exporatory Pilot Study.
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Status: Enrolling
Updated:  12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Status: Enrolling
Updated: 12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Status: Enrolling
Updated:  12/31/1969
Legacy Good Samaritan Medical Center
mi
from
Portland, OR
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Status: Enrolling
Updated: 12/31/1969
Legacy Good Samaritan Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation
A Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation
A Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
Computer-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Marijuana Use in Pregnancy: Planning a Stage II Trial
Status: Enrolling
Updated:  12/31/1969
Wayne State University
mi
from
Detroit, MI
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
Computer-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Marijuana Use in Pregnancy: Planning a Stage II Trial
Status: Enrolling
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
Addressing Cervical Cancer Disparity in South Florida: CBPR in Action
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
Addressing Cervical Cancer Disparity in South Florida: CBPR in Action
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Physicians Hair Institute
mi
from
Tucson, AZ
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Physicians Hair Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Tennessee Clinical Research Center
mi
from
Nashville, TN
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Tennessee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Sinclair Dermatology
mi
from
East Melbourne,
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Sinclair Dermatology
mi
from
East Melbourne,
Click here to add this to my saved trials
Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Status: Enrolling
Updated:  12/31/1969
UAB Personal Health Clinic
mi
from
Birmingham, AL
Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Status: Enrolling
Updated: 12/31/1969
UAB Personal Health Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase I Study of Nicotinamide for Early Onset Preeclampsia
Phase I Study of Nicotinamide for Early Onset Preeclampsia
Status: Enrolling
Updated:  12/31/1969
University of North Carolina Women's Hospital
mi
from
Chapel Hill, NC
Phase I Study of Nicotinamide for Early Onset Preeclampsia
Phase I Study of Nicotinamide for Early Onset Preeclampsia
Status: Enrolling
Updated: 12/31/1969
University of North Carolina Women's Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
MENVEO® Pregnancy Registry: an Observational Study on the Safety of MENVEO Exposure in Pregnant Women and Their Offspring
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Wilmington, NC
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
MENVEO® Pregnancy Registry: an Observational Study on the Safety of MENVEO Exposure in Pregnant Women and Their Offspring
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
David Archer, MD
mi
from
Norfolk, VA
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
David Archer, MD
mi
from
Norfolk, VA
Click here to add this to my saved trials
Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity
Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity: a Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Temple University
mi
from
Philadelphia, PA
Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity
Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Magnetic Resonance Elastography in Hydrocephalus
Magnetic Resonance Elastography in Hydrocephalus
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Magnetic Resonance Elastography in Hydrocephalus
Magnetic Resonance Elastography in Hydrocephalus
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
San Diego Sexual Medicine
mi
from
San Diego, CA
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Center for Marital and Sexual Health of South Florida
mi
from
West Palm Beach, FL
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Center for Marital and Sexual Health of South Florida
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Tulane University School of Medicine
mi
from
New Orleans, LA
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Tulane University School of Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Cooper Research Institute
mi
from
Camden, NJ
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Cooper Research Institute
mi
from
Camden, NJ
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Manhattan Medical Research
mi
from
New York, NY
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Manhattan Medical Research
mi
from
New York, NY
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
The Miriam Hospital / The Men's Health Center
mi
from
Providence, RI
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
The Miriam Hospital / The Men's Health Center
mi
from
Providence, RI
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Australian Centre for Sexual Health
mi
from
Saint Leonards,
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Australian Centre for Sexual Health
mi
from
Saint Leonards,
Click here to add this to my saved trials
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated:  12/31/1969
Urologic Consultants of Southeastern Pennsylvania
mi
from
Bala-Cynwyd, PA
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Status: Enrolling
Updated: 12/31/1969
Urologic Consultants of Southeastern Pennsylvania
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women
Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women
Status: Enrolling
Updated:  12/31/1969
University of Vermont
mi
from
Burlington, VT
Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women
Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women
Status: Enrolling
Updated: 12/31/1969
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
Deciphering the Breast Cancer Exercise Paradox: The Role of DNA Repair and Inflammation
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
Deciphering the Breast Cancer Exercise Paradox: The Role of DNA Repair and Inflammation
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated:  12/31/1969
Precision Trials
mi
from
Phoenix, AZ
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated: 12/31/1969
Precision Trials
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated:  12/31/1969
Southern Clinical Research Associates
mi
from
Metairie, LA
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated: 12/31/1969
Southern Clinical Research Associates
mi
from
Metairie, LA
Click here to add this to my saved trials
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated:  12/31/1969
Sites Various
mi
from
Pleven,
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated: 12/31/1969
Sites Various
mi
from
Pleven,
Click here to add this to my saved trials
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated:  12/31/1969
Lyndhurst Clinical Research
mi
from
Winston-Salem, NC
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Status: Enrolling
Updated: 12/31/1969
Lyndhurst Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
Status: Enrolling
Updated:  12/31/1969
Tulane University Clinical Translational Unit
mi
from
New Orleans, LA
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
Status: Enrolling
Updated: 12/31/1969
Tulane University Clinical Translational Unit
mi
from
New Orleans, LA
Click here to add this to my saved trials